Aspen Aerogels
ASPN
45 hedge funds and large institutions have $81.9M invested in Aspen Aerogels in 2018 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 16 increasing their positions, 8 reducing their positions, and 6 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
100% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 8
14% more capital invested
Capital invested by funds: $72.1M → $81.9M (+$9.8M)
1.3% less ownership
Funds ownership: 71.31% → 70.01% (-1.3%)
12% less funds holding
Funds holding: 51 → 45 (-6)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 6
Top Buyers
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
+$2.16M |
| 2 |
CPA
Cowen Prime Advisors
New York
|
+$852K |
| 3 |
Renaissance Technologies
New York
|
+$257K |
| 4 |
RA
Royce & Associates
New York
|
+$249K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$184K |
Top Sellers
ASPN Hedge Fund Activity: Q2 2018 in Review
45 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Aspen Aerogels (ASPN) for Q2 2018, worth a combined $81.9M — up 14% from $72.1M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of ASPN and 0 opened new positions — a net loss of 6 holders — while 8 trimmed existing stakes and 16 added.
The largest buyer was Ariel Investments, adding an estimated $2.16M. The largest seller was AWM Investment Company, exiting entirely with an estimated $1.37M sold.
- 45 institutional investors held Aspen Aerogels (ASPN) as of Q2 2018, down from 51 in Q1 2018.
- Funds reported $81.9M of Aspen Aerogels stock for Q2 2018, up 14% quarter-over-quarter.
- 0 funds opened new Aspen Aerogels positions in Q2 2018 and 6 closed out, a net change of -6 holders.
- The largest Aspen Aerogels buyer in Q2 2018 was Ariel Investments, an estimated $2.16M added.
- The largest Aspen Aerogels seller in Q2 2018 was AWM Investment Company, an estimated $1.37M sold.
Based on aggregated 13F filings for Q2 2018.